ESC Premium Access

Resistant hypertension

Event: ESC CONGRESS 2016
Topic: Treatment of hypertension
Session type: Advances in Science
Date: 28 August 2016
Time: 11:00 - 12:30


5 presentations in this session

State of the art in treatment of resistant hypertension.

Speaker: Professor R. Schmieder (Erlangen, DE)

Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study

Speaker: Professor H. Chen (Rochester Mn, US)

The role of adding spironolactone and renal denervation in true resistant hypertension. one-year outcomes of randomized study.

Speaker: Doctor J. Rosa (Nymburk, CZ)

SYMPLICITY HTN-3 screen failure patient cohort analysis

Speaker: Doctor R. Waksman (Washington, DC, US)

Future direction for research in management of resistant hypertension.

Speaker: Professor A. Pathak (Monaco, MC)

5 speakers from this session

Professor Roland Schmieder

University Hospital Erlangen, Department of Nephrology and Hypertension, Erlangen (Germany)
22 presentations
0 follower

Professor Horng Chen

Mayo Clinic, Rochester Mn (United States of America)
0 follower

Doctor Jan Rosa

Hospital of Nymburk, Nymburk (Czechia)
0 follower

Doctor Ron Waksman

Medstar Washington Hospital Centre, Washington, DC (United States of America)
3 presentations
0 follower

Professor Atul Pathak

The Princess Grace Hospital Centre, Monaco (Monaco)
11 presentations
0 follower

This platform is supported by

logo Novo Nordisk